1967
DOI: 10.1038/2161038a0
|View full text |Cite
|
Sign up to set email alerts
|

Pink Spot, p-Tyramine and Schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1968
1968
2007
2007

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…(1974) to be less than 1 psi24 h. The excretion of mand p-tyramine vary considerably between subjects, hence the different means in the excretions in Table 3. The excretion rate of m-and p-tyramine in man is comparable to those reported in the literature (JEP-SON er al., 1960;PERRY & SCHROEDER, 1963;COWARD er al., 1964;VOGEL et al, 1967;KING et al, 1974;SLINGSBY & BOULTON, 1976). Table 2, the concentrations of the three amines measured did not significantly change 1 h after eating.…”
Section: Discussionmentioning
confidence: 89%
“…(1974) to be less than 1 psi24 h. The excretion of mand p-tyramine vary considerably between subjects, hence the different means in the excretions in Table 3. The excretion rate of m-and p-tyramine in man is comparable to those reported in the literature (JEP-SON er al., 1960;PERRY & SCHROEDER, 1963;COWARD er al., 1964;VOGEL et al, 1967;KING et al, 1974;SLINGSBY & BOULTON, 1976). Table 2, the concentrations of the three amines measured did not significantly change 1 h after eating.…”
Section: Discussionmentioning
confidence: 89%
“…The results from these studies, often but not always replicated (Anderson et al, 1984), correlated levels of PEA, TYR, TRYP, or their metabolites in blood and/or urine with methylphenidate and AMPH exposure (Borison et al, 1975), hypertension (Andrew et al, 1993), and hepatic encephalopathy (Manghani et al, 1975) as well as mental conditions including schizophrenia (Boulton et al, 1967;Vogel, 1967;Faurbye, 1968;Zeller et al, 1976;Sandler & Reynolds, 1976;Boulton, 1980;Boulton, 1982;Szymnanski et al, 1987;Myojin et al, 1989;O'Reilly et al, 1991;O'Reilly & Davis, 1994;Buckland et al, 1997), Tourette's syndrome (Baker et al, 1993), attention deficit hyperactivity disorder (i.e. ADHD; Baker et al 1991;Kusaga, 2002), migraine (Hannington, 1967;Smith et al, 1970;Sever, 1979;D'Andrea et al, 2003b) and other headache Aridon et al, 2004), and depression Reynolds, 1979;Sandler et al, 1980;Chance et al, 1985;Davis & Boulton, 1994).…”
Section: Trace Amines In Human Health and Disease-withmentioning
confidence: 99%